Member Exclusive

Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds

This special report, brought to MedChemNet members by Future Medicinal Chemistry, discusses progress in the development of novel anticancer drugs based on ruthenium(II)- and iron(II)-cyclopentadienyl scaffolds.


Please sign in or register for FREE

No comments yet.